Related Experiment Videos
Structure-based design approaches to cell wall biosynthesis inhibitors.
Alan H Katz1, Craig E Caufield
1Wyeth-Ayerst Research, Princeton, NJ 08540, USA. KATZA@wyeth.com
Current Pharmaceutical Design
|April 8, 2003
Summary
This review explores using protein and NMR structures to design new antibiotics targeting bacterial cell wall biosynthesis. Understanding structural differences and resistance mechanisms is key to developing effective antibacterial agents.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Microbiology
Background:
- Bacterial cell wall biosynthesis is a validated target for antibacterial drug development.
- Peptidoglycan synthesis involves multiple enzymatic steps, offering various targets for inhibition.
- Protein and Nuclear Magnetic Resonance (NMR) structures provide crucial insights for rational drug design.
Purpose of the Study:
- To review the application of protein and NMR structures in designing novel antibiotics.
- To highlight key enzymes and pathways in cell wall biosynthesis targeted by structural approaches.
- To discuss challenges and opportunities in developing structure-based antibacterials.
Main Methods:
- Analysis of published literature on structure-based antibiotic design.
- Focus on enzymes like Mur enzymes, penicillin-binding proteins, lactamases, and d-Ala-d-Ala ligase.
- Examination of structural variations across bacterial species and their implications.
Main Results:
- Structural information has been instrumental in designing inhibitors for several cell wall biosynthesis enzymes.
- Significant structural differences between bacterial species (e.g., MurB) present design challenges.
- Understanding resistance mechanisms, such as mutations in d-Ala-d-Ala ligase affecting antibiotic binding, is crucial.
Conclusions:
- Protein and NMR structures are valuable tools for developing new antibiotics against bacterial cell wall synthesis.
- Addressing inter-species structural variability and acquired resistance is essential for effective drug discovery.
- Structure-guided design holds promise for overcoming current challenges in antibacterial therapy.